RE:RE:RE:Lets have some Valuation fun...As I recall, the subject of whether the rights to selling Immunocidin along with all the other animal health products at the time that portion of the business was sold to Quinonel was never specifically addressed by Bioniche at the time. As I was curious about that aspect at the time of animal health sale, I was alert to any announcement about Immunocin and/or MCNA rights for animal health being transferred and never saw any indication of whether Bioniche kept any rights for Immunocin or not. Perhaps Telesta would be forth coming with that answer if asked. Since nothing was mentioned, I assume rights to Immunocidin for animals was transferred upon the sale of animal health. I would think Bioiniche would have retained rights to MCNA for this potential human health application, but who knows. Perhaps someone with a working relationship with current management could ask about this and receive a response.